← Back to Clinical Trials
Recruiting NCT07187245

NCT07187245 Feasibility of the Reality PAWS Program for Children in Isolation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07187245
Status Recruiting
Phase
Sponsor Children's Hospital Colorado
Condition Inpatient Pediatric Care
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2026-01-29
Primary Completion 2026-07-01

Trial Parameters

Condition Inpatient Pediatric Care
Sponsor Children's Hospital Colorado
Study Type INTERVENTIONAL
Phase N/A
Enrollment 50
Sex ALL
Min Age 8 Years
Max Age 21 Years
Start Date 2026-01-29
Completion 2026-07-01
Interventions
Reality PAWS Program via Meta Quest 3 VR

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to learn if a mixed reality program, Reality PAWS, delivered on a Meta Quest 3 VR headset, is a feasible intervention for pediatric patients in isolation. It will also evaluate the safety of the program and its effect on pain, anxiety, and loneliness. The main questions the study aims to answer are: What is the feasibility of utilizing Reality PAWS MR as a substitute for in-person dog therapy for children under isolation precautions? Are patients compliant with using Reality PAWS MR? What are the interventional outcomes of Reality PAWS MR? Participants will: Wear a Meta Quest 3 VR headset with the Reality PAWS program. Interact with the program. Answer surveys regarding demographics, anxiety, pain, loneliness, sickness, perceived exertion, and immersion in the program.

Eligibility Criteria

Inclusion Criteria: * Children 8 to 21 years old admitted to Children's Hospital Colorado or Children's Hospital Los Angeles * Children who are English-speaking (legal guardian may be English-speaking or Spanish-speaking) * Children within the normal range of development will be recruited for this study. Exclusion Criteria: * Traumatic brain injury, neurological disorders, neurodevelopmental issues, or other neurological disorders and comorbidities that may confound study outcomes and administration of the study protocol and metrics (e.g., visual field disturbances, frequent nausea/ vomiting, not medically stable, intellectual disability) * Children with visual, auditory, or tactile deficits that would interfere with the ability to complete the experimental tasks * Children with a history of seizure disorder * Children currently sick with flu-like symptoms or experiencing a headache or earache * Children with known or suspected motion sickness * Children with cochlear implants or pace

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology